Modes of action of Freund's adjuvants in experimental models of autoimmune diseases

Journal of Leukocyte Biology

Volumn 70, Issue 6, 2001, Pages 849-860

  Billiau, Alfons ^a   Matthys, Patrick ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Adjuvant; Dendritic cells; Freund

Indexed keywords

ANTIBODY; AUTOANTIGEN; CYTOKINE; FREUND ADJUVANT; MYCOBACTERIUM ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; BONE MARROW CELL; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DRUG UPTAKE; EFFECTOR CELL; EXPERIMENTAL MODEL; HEMATOPOIETIC SYSTEM; IMMUNOPHARMACOLOGY; LEUKOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR PHAGOCYTE; MYCOBACTERIUM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FREUND'S ADJUVANT; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

EID: 0035217962     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. The mode of action of immunologic adjuvants
2. Allergic irritability. The formation of antisheep hemolytic amboceptor in the normal and tuberculous guinea pig
3. The technic of producing tuberculin type of sensitization with eggwhite in tuberculous guinea pigs
4. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys
5. Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water-in-oil emulsion
6. Role of adjuvants in the production of delayed hypersensitivity
7. Autoimmunity to type II collagen: An experimental model of arthritis
8. Immunisation against heterologous type II collagen induces arthritis in mice
9. + myeloid cells
10. Animal models of rheumatoid arthritis
11. Vaccination and genetic experiments demonstrate that adjuvant-oil-induced arthritis and homologous type II collagen-induced arthritis in the same rat strain are different diseases
12. The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats
13. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats
14. Pristane-induced arthritis is CD4+ T cell-dependent
15. Development of arthritis, periarthritis and periostitis in rats given adjuvants
16. A new spin on an old model: In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat
17. Polyclonal T cells transfer oil-induced arthritis
18. Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases?
19. Complete Freund's adjuvant induces an earlier and more severe arthritis in Mrl-lpr mice
20. NIH intramural recommendations for the research use of complete Freund's adjuvant
21. CCAC guidelines on acceptable immunological procedures
22. The use of Freund's complete adjuvant
23. Bacteriological and pathological study of animals given Freund adjuvant
24. Granulomatous lesions in mice produced by Freund's adjuvant
25. The local and systemic effects of Freund's adjuvant and its fractions
26. Adjuvants in the induction of suppressor cells
27. Suppressor T cells for delayed-type hypersensitivity in susceptible mice infected with Mycobacterium lepraemurium
28. Biological properties of factors secreted by antigen-reactive suppressor cells in mice infected with Mycobacterium lepraemurium
29. Cellular target of in vitro-induced suppressor cells derived from the spleen of Mycobacterium lepraemurium-infected mice and role of IFN-γ in their development
30. Early accumulation of suppressor cell precursors in the spleen of Mycobacterium lepraemurium-infected mice and analysis of their in vitro-induced maturation
31. Nonspecific immunopotentiators and pregnancy loss: Complete Freund adjuvant reverses high fetal resorption rate in CBA X DBA/2 mouse combination
32. Mouse model for the treatment of immune pregnancy loss
33. Immune features in complete Freund adjuvant-treated CBA/J mouse model
34. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice
35. Possible mechanisms of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaceinated mice
36. Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity
37. Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible mice
38. TNF-α dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis
39. Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis
40. Anti-oxidants inhibit the enhancement of the immune response caused by oil adjuvants
41. Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: Induction of colony-stimulating activity and stimulation of stem cell proliferation
42. Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6,6′-dimycolate (cord factor)
43. Macrophage activation: Lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes of c-fos, KC, JE, and tumor necrosis factor-α
44. Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects
45. Extolling the diversity of bacterial endotoxins
46. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components
47. Cytokine production by Mycobacterium tuberculosis lipoarabinomannan
48. Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan
49. Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensivity-type granulomas in mice
50. Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells
51. Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex
52. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides
53. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
54. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis
55. 1311-labelled protein antigens from the circulation of the mouse
56. Effectiveness of lipid and lipidophilic substances as adjuvants
57. Separate application of adjuvant and antigen: The effect of water-in-oil emulsion on the splenic plaque-forming cell response to sheep red blood cells in mice
58. The mode of action of mineral-oil emulsion adjuvants on antibody production in mice
59. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: Involvement of Toll-like receptors
60. Sensing pathogens and tuning immune responses
61. Stimulation of phagocytosis in relation to the mechanism of action of adjuvants
62. Ultrastructure of the antigen-retaining reticulum of lymph node follicles as shown by high-resolution autoradiography
63. 1251-labelled Salmonella adelaide flagellin following injection into the rat in the presence of Freund's complete adjuvant
64. Lymph node localization and whole body distribution of radioiodinated encephalitogenic polypeptide in guinea-pigs
65. The localization of antigen in relation to specific antibody-producing cells. 1. Use of a synthetic polypeptide [(T,G,)-A-L] labelled with iodine-125
66. 14C-labelled hexadecane
67. Dendritic cells internalize vaccine adjuvant after intramuscular injection
68. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response
69. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant
70. Collagen-induced arthritis in DBA/1 mice: Cytokine gene activation following immunization with Type II collagen
71. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection
72. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice
73. Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retrovirus
74. Nonspecific and immune-specific up-regulation of cytokines in rabbit dermal tuberculous (BCG) lesions
75. Early interleukin-12 production by macrophages in response to mycobacterial infections depends on interferon γ and tumor necrosis factor
76. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection
77. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice
78. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice
79. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis
80. Macrophages are a significant source of type 1 cytokines during mycobacterial infection
81. Interleukin-6 production in Mycobacterium bovis BCG-infected mice
82. Production of TNF-α IL-6 and TGF-β, and expression of receptors for TNF-α, and IL-6, during murine Mycobacterium avium infection
83. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses
84. Secretion of interleukin 6 by human monocytes stimulated by muramyl dipeptide and tumor necrosis factor alpha
85. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-6 and NF-κB
86. Ligands for natural killer cell receptors: Redundancy or specificity
87. The protective effect of IFN-γ in experimental autoimmune diseases: A central role of mycobacterial adjuvant-induced myelopoiesis
88. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis
89. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: Analysis of local and regional cytokine and chemokine networks
90. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components
91. Mice that lack the interferon-γ receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide
92. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection
93. Induction of granulomas in interferon-γ gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis
94. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
95. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor 1 (TNF-RI) knockout mice and by treatment with soluble TNF-RI
96. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
97. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
98. Migration of hematogenous cells through the bloodbrain barrier and the initiation of CNS inflammation
99. T-lymphocyte entry into the central nervous system
100. Contra: Evidence against a primary lesion in the target organ in autoimmune diesease
101. Increased bone marrow production of granulocytes and mononuclear phagocytes induced by mycobacterial adjuvants: Improved recovery of leukopoiesis in mice after cyclophosphamide treatment
102. Stimulatory effects of polar glycopeptidoliplds of Mycobacterium chelonae on murine haematopoietic stem cells and megakaryocyte progenitors
103. Trehalose dimycolate enhances resistance to infection in neutropenic animals
104. Hematopoletic remodelling in interferon-γ-deficient mice infected with mycobacteria
105. Bone marrow changes in adjuvant-induced and collagen-induced arthritis. Interleukin-1 and interleukin-6 activity and abnormal myelopoiesis
106. + myelopoiesis induced by complete Freund's adjuvant (CFA): A clue to the paradoxical effects of IFN-γ in autoimmune disease models